Erratum to: Sustained response off‐treatment in eltrombopag‐treated adult patients with ITP who are refractory or relapsed after first‐line steroids: Primary, final, and ad‐hoc analyses of the Phase II TAPER trial

Ähnliche Einträge

• Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy
  von: Matthew A. Lunning, et al.
  Veröffentlicht: (2024)
• Safety and efficacy of baricitinib in steroid‐resistant or relapsed immune thrombocytopenia: An open‐label pilot study
  von: Peng Zhao, et al.
  Veröffentlicht: (2024)
• Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML
  von: Stefan O. Ciurea, et al.
  Veröffentlicht: (2024)
• Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients
  von: Sanfang Tu, et al.
  Veröffentlicht: (2024)
• Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma
  von: Sam Yuen, et al.
  Veröffentlicht: (2024)